Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.4300 (0.93%) ($5.3100 - $5.5400) on Mon. Dec. 9, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.44% (three month average) | RSI | 44 | Latest Price | $5.4300(0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.6% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(66%) ARKK(63%) XBI(63%) IBB(57%) IPO(55%) | Factors Impacting CGEN price | CGEN will decline at least -1.72% in a week (0% probabilities). VXX(-37%) VIXM(-33%) UUP(-11%) TLT(-4%) SHY(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.72% (StdDev 3.44%) | Hourly BBV | 0 () | Intraday Trend | 2.1% | | | |
|
Resistance Level | $5.63 | 5 Day Moving Average | $5.4(0.56%) | 10 Day Moving Average | $5.64(-3.72%) | 20 Day Moving Average | $5.63(-3.55%) | To recent high | -10.8% | To recent low | 8.4% | Market Cap | $449m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |